Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Solis Women's Health adds molecular imaging to its diagnostic tools folio

Dilon Technologies : 02 July, 2008  (Application Story)
Solis Women's Health, with eight centres across the Dallas-Fort Worth area devoted entirely to mammography and breast imaging, has added molecular imaging technology to the diagnostic tools it has available in its Dallas-Fort Worth locations.
The molecular imaging is performed with the Dilon 6800, a high-resolution, small field-of-view gamma camera, optimised to perform Breast-Specific Gamma Imaging (BSGI). The technology is initially being implemented at Solis' Central Plano location, with further implementations planned at Solis locations throughout the Dallas-Fort Worth area.

BSGI is a molecular breast imaging technique that can see lesions independent of tissue density and discover very early stage cancers. BSGI serves as a complementary diagnostic adjunct procedure to mammography and Ultrasound for difficult-to-diagnose patients. With BSGI, the patient receives a pharmaceutical tracing agent that is absorbed by all the cells in the body. Due to their increased rate of metabolic activity, cancerous cells in the breast absorb a greater amount of the tracing agent than normal, healthy cells and generally appear as ‘hot spots’ on the BSGI image.

Solis has been using the Dilon 6800 in its Solis-Bertrand Breast Center in Greensboro, North Carolina, USA, for more than a year. Molecular imaging will be used as a part of Solis' advanced imaging programme for breast diagnosis, which also includes the use of breast MRI, when appropriate.

'BSGI has proven to be an important adjunct to mammography and Ultrasound in the diagnosis of breast cancer at the Solis-Bertrand Center, and we are excited to be the first in the Metroplex to offer this important advance in care,' said Brad Hummel, chief executive officer of Solis.

'At Solis our commitment is to the women of our communities, and this commitment extends to selecting technologies that demonstrate diagnostic value in our mission to diagnose cancers when they are small and at their most treatable. We studied the BSGI extensively at our centre in Greensboro, and determined that it offered benefits that we needed to bring to the Metroplex,' said Hummel.

Bob Moussa, chief executive officer of Dilon Technologies added, 'We are delighted to have an institution as prestigious as Solis Women's Health include our advanced technology as part of their diagnostic offering. It speaks volumes for their commitment to enhancing the standard of health care in the communities in which they operate. By working closely together, Solis and Dilon will continue to help the fight against cancer.'
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   Â© 2012 ProHealthServiceZone.com
Netgains Logo